Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.4%

2 terminated/withdrawn out of 27 trials

Success Rate

81.8%

-4.7% vs industry average

Late-Stage Pipeline

30%

8 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

8(40.0%)

Phase 3

6(30.0%)

N/A

3(15.0%)

Phase 4

2(10.0%)

Phase 1

1(5.0%)

20Total

Phase 2(8)

Phase 3(6)

N/A(3)

Phase 4(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT03236649Phase 3Terminated

The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects

Role: collaborator

NCT03010735Phase 2Completed

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

Role: collaborator

NCT03010696Completed

The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)

Role: collaborator

NCT03719820Unknown

Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )

Role: collaborator

NCT02913469Phase 4Unknown

Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction

Role: lead

NCT01873547Phase 3Completed

Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China

Role: lead

NCT01929434Phase 3Completed

Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis

Role: lead

NCT03024749Unknown

Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas

Role: collaborator

NCT02384837Completed

Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up

Role: lead

NCT01962428Phase 4Completed

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Role: lead

NCT00714077Unknown

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

Role: collaborator

NCT02614820Not ApplicableUnknown

The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD

Role: lead

NCT02543099Phase 3Unknown

Efficacy and Safety Study of Policosanol

Role: lead

NCT01776866Not ApplicableCompleted

Image Content Analysis of Dural-axis Rotational Versus Standard Coronary Angiography

Role: lead

NCT01308671Not ApplicableUnknown

Influence of Varenicline on the Antiplatelet Action of Clopidogrel

Role: lead

NCT01812330Phase 3Unknown

Efficacy and Safety Study of Ticagrelor

Role: lead

NCT01625533Completed

Safety and Efficacy Study of Dual-axis Rotational Versus Standard Coronary Angiography

Role: lead

NCT01291329Phase 2Completed

Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)

Role: collaborator

NCT01389453Phase 2Withdrawn

The Clinical Trial Research of Stem Cell Transplantation Treats Cerebral

Role: lead

NCT01718587Phase 1Unknown

Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients

Role: lead